Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Inventory (2016 - 2025)

Medifast's Inventory history spans 16 years, with the latest figure at $20.2 million for Q4 2025.

  • For Q4 2025, Inventory fell 52.32% year-over-year to $20.2 million; the TTM value through Dec 2025 reached $20.2 million, down 52.32%, while the annual FY2025 figure was $20.2 million, 52.32% down from the prior year.
  • Inventory reached $20.2 million in Q4 2025 per MED's latest filing, down from $23.2 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $189.0 million in Q1 2022 to a low of $20.2 million in Q4 2025.
  • Average Inventory over 5 years is $81.9 million, with a median of $60.2 million recorded in 2021.
  • Peak YoY movement for Inventory: surged 237.21% in 2021, then tumbled 59.92% in 2023.
  • A 5-year view of Inventory shows it stood at $180.0 million in 2021, then plummeted by 33.98% to $118.9 million in 2022, then crashed by 54.07% to $54.6 million in 2023, then fell by 22.29% to $42.4 million in 2024, then tumbled by 52.32% to $20.2 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Inventory are $20.2 million (Q4 2025), $23.2 million (Q3 2025), and $30.2 million (Q2 2025).